Status:
RECRUITING
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this observational study is to learn about the Effects of neoadjuvant therapy with carboplatin, paclitaxel combined with anti-PD-1 drugs on pain, anxiety and depression in patients with op...
Eligibility Criteria
Inclusion
- \- 1: Clinical diagnosis of head and neck squamous cell carcinoma (stage I-IVA), without prior treatment, and planning to undergo either surgical treatment alone or surgical treatment combined with chemotherapy and immunotherapy.
- 2: Ability to speak Chinese and possess basic reading and writing skills.
Exclusion
- 1: Presence of mental illnesses such as dementia or delirium.
- 2: Active use of narcotic drugs, including consuming alcohol more than 4 times per day or more than 4 times per week.
- 3: Patients who alter their treatment plan during the course of treatment.
- 4: Current or prior use of antidepressants.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT06575322
Start Date
September 1 2024
End Date
March 1 2027
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guanzhou, Guangdong, China, 510000